A. Borgne

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

L Meijer, L. Meijer, M. Inagaki, 1997, European journal of biochemistry.

Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatin remodeling

A. Escargueil, L. Meijer, L. Meijer, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Sequential Dephosphorylation of p34cdc2 on Thr-14 and Tyr-15 at the Prophase/Metaphase Transition*

Laurent Meijer, L. Meijer, A. Borgne, 1996, The Journal of Biological Chemistry.

Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment

J. Hickman, L. Meijer, A. Borgne, 2006, Oncogene.

Intra-M Phase-promoting Factor Phosphorylation of Cyclin B at the Prophase/Metaphase Transition*

L. Meijer, L. Meijer, A. Borgne, 1999, The Journal of Biological Chemistry.

The role of cyclin-dependent kinases in apoptosis.

A. Borgne, R. Golsteyn, 2003, Progress in cell cycle research.

The G1/S cyclin Cig2p during meiosis in fission yeast.

P. Nurse, H. Murakami, A. Borgne, 2002, Molecular biology of the cell.

Purification of GSK-3 by affinity chromatography on immobilized axin.

F. Costantini, L. Meijer, A. Borgne, 2000, Protein expression and purification.

The Spd1p S phase inhibitor can activate the DNA replication checkpoint pathway in fission yeast.

P. Nurse, A. Borgne, 2000, Journal of cell science.